Delparantag

DB12955InvestigationalSmall molecule

Delparantag has been used in trials studying the treatment of Angioplasty, Coronary Artery Disease (CAD), and Percutaneous Coronary Intervention.

Chemical structure of Delparantag
Formula / weight
C56H79N13O12 · 1126.327 g/mol (avg)
Code names
PMX-60056

Resolves to

Compound
UNIIFSY46235ZOCAS872454-31-4ChEMBLCHEMBL2107820PubChem51349239
Structure
InChIKeyPWFIFNGOPQUNIT-ITMZJIMRSA-NSMILESCOC1=CC=C(NC(=O)[C@H](CCCCN)NC(=O)C2=CC(NC(=O)[C@H](CCCCN)NC(=O)C3=CC(NC(=O)[C@H](CCCCN)NC(=O)C4=CC(NC(=O)[C@@H](N)CCCCN)=CC=C4OC)=CC=C3OC)=CC=C2OC)C=C1C(N)=O
Targets
P01008SERPINC1

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Delparantag, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In